March 11-14, 2026





A focused exploration of heart failure pharmacotherapy — from Na⁺/K⁺ ATPase and Beta-AR to MRAs, SGLT2, GLP-1, cGMP pathways, precision care, clinical trials, inflammasome targets, CKD and albuminuria, and iron replacement

A deep dive into HFpEF, hypertrophic cardiomyopathy (HCM), transthyretin amyloidosis (TTR), and the role of biopsy and advanced diagnostics in understanding diastolic dysfunction

Explore cutting-edge strategies to predict and enhance myocardial recovery in cardiogenic shock — from mechanical circulatory support to next-generation internal and external devices and wearables

From Training to Transformation — Fellows Connect With Faculty and Map a Career in Heart Failure

Transforming Heart Failure Systems: Cost, Care Teams, AI, and Decision Algorithms

Invitation-only: A collaborative think tank for clinical experts to share research, challenge assumptions, and reimagine heart failure care delivery.
Hawaii International Heart Failure Symposium
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.